A. Bryskier Clinical Microbiology and Infection

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

K. Kümmerer, A. Henninger Clinical Microbiology and Infection

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

Approach to diagnosis of infective endocarditis

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

K. Kümmerer, A. Henninger Clinical Microbiology and Infection

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

F. Rodríguez-Gómez, O. Cuevas, J. Anguita, P. Muñoz

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

A. Bryskier Clinical Microbiology and Infection

N.C. Weightman, S. Mitra, P.T. Kipling

Structure of grepafloxacin relative to activity and safety profile

Vector control: a cornerstone in the malaria elimination campaign

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Training for the infectious diseases speciality in Norway

F. Grill, P. Muñoz, R. Jofre, E. Bouza

Laboratory diagnosis and biosafety issues of biological warfare agents

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Levofloxacin in the treatment of ventilator-associated pneumonia

Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens* M. Kanellopoulou, A. Makri,

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

Laboratory diagnosis of Clostridium difficile disease

Recent developments in staphylococcal scalded skin syndrome

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

G.R. Davies Clinical Microbiology and Infection

Pathogenesis of catheter-related infections: lessons for new designs

A. Bryskier Clinical Microbiology and Infection

Antibacterial drug discovery in the 21st century

Community-acquired pneumonia: epidemiologic and clinical consideration

Abstracts cont. Clinical Microbiology and Infection

Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis S.R. Norrby, J. Quinn, M. Rangaraju,

Training in infectious diseases and tropical medicine in Britain

Antimicrobial drug development – the past, the present, and the future

Definition of the Clinical Antibacterial Spectrum of Activity

Clinical infection services—the Leiden experience

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

W. Eugene Sanders, Christine C. Sanders

Evaluation of the performance of the Helico Blot 2

Overview of cefixime use in community-acquired infections

A. Norberg, C.E. Nord, B. Evengård Clinical Microbiology and Infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

D.L. Monnet, T.L. Sørensen Clinical Microbiology and Infection

Carratalà J. Clinical Microbiology and Infection

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

N. Markeas, G. Stamos, I. Paraskakis, A. Giokas, G. Pistevos

J.L. Balcázar Clinical Microbiology and Infection

Clinical microbiological case: thermointolerant microorganism growth in blood cultures and catheter tip M. Blasco-Navalpotro, M. Jordán, J.J. Camarena,

N.C. Weightman, S. Mitra, P.T. Kipling

Typing of Clostridium difficile

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Decision-making in otitis media in children, Part I: epidemiologic data and definitions for a reliable cost-effectiveness analysis Bernard Grenier Clinical.

Comparative study of pediculicidal effect of medical plants

Localized Mycobacterium avium complex infection in a patient on HAART

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Ketolides—telithromycin, an example of a new class of antibacterial agents A. Bryskier Clinical Microbiology and Infection Volume 6, Issue 12, Pages 661-669 (December 2000) DOI: 10.1046/j.1469-0691.2000.00185.x Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Ketolide definition. Clinical Microbiology and Infection 2000 6, 661-669DOI: (10.1046/j.1469-0691.2000.00185.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Carbamate ketolide: chemical structure. Clinical Microbiology and Infection 2000 6, 661-669DOI: (10.1046/j.1469-0691.2000.00185.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 3 Properties of ketolides. Clinical Microbiology and Infection 2000 6, 661-669DOI: (10.1046/j.1469-0691.2000.00185.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 4 Telithromycin. Clinical Microbiology and Infection 2000 6, 661-669DOI: (10.1046/j.1469-0691.2000.00185.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 5 ABT 773. Clinical Microbiology and Infection 2000 6, 661-669DOI: (10.1046/j.1469-0691.2000.00185.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions